功能性粉样蛋白作为针对药物输送和免疫治疗的多功能平台
Brianna McVay1,2, Dana Wolfe1,2, Ayyalusamy Ramamoorthy1,2,3
1Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, 2525 Pottsdamer Street, Tallahassee, Florida 32310, United States.
Langmuir : the ACS journal of surfaces and colloids
|September 17, 2025
概括
粉样纤维素来自自组装,显示承诺作为药物输送和免疫治疗的稳定生物材料. 工程化粉样蛋白纳米结构提供有针对性的传递和增强的免疫反应,推进精确医学.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 自组装分子是新型材料设计的关键.
- 已知来自神经退行性疾病的粉样纤维是稳定的,生物相容的纳米结构.
- 它们在治疗和免疫调节方面的潜力越来越得到认可.
研究的目的:
- 审查功能性粉样纳米结构的设计和应用.
- 突出它们在向药物输送和免疫治疗中的作用.
- 讨论基于粉样蛋白的工程平台的进展.
主要方法:
- 关于粉样纤维素自我组装和功能化的最近研究的综述.
- 对粉样纤维的封装和向特性进行分析.
- 检查将粉样蛋白与脂质体和水凝结合的混合系统.
主要成果:
- 粉样纤维素可以封装小分子,并被表面功能化以提供有针对性的输送.
- 它们使环境响应性药物释放成为可能,并显示出疫苗开发的潜力.
- 粉样骨架作为载体和辅助剂,增强免疫活性.
结论:
- 工程化粉样蛋白纳米结构为向药物输送和免疫治疗提供了多功能平台.
- 混合化与现有的输送工具可以提高治疗效率并降低毒性.
- 进一步了解这些平台可能会推动精准医学和创新的生物材料设计.
相关概念视频
Amyloid Fibrils
11.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Amyloid Fibrils
6.3K
6.3K
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


